警惕！2026年上海议价红线，或将调整至省级挂网最低价

Core Viewpoint - The article discusses the governance of medical consumables pricing in Shanghai, outlining the tasks set by the National Medical Insurance Administration (NMI) for 2026, focusing on price monitoring, collaborative pricing, and the establishment of a pricing overview for medical consumables [1][2][5]. Group 1: Price Monitoring and Governance - The NMI will conduct a retrospective review of the prices established through previous national medical consumables procurement and will monitor compliance across provinces [1][2]. - Each province is required to self-examine the execution of the procurement results and the corresponding online pricing of medical consumables [1][2]. Group 2: Collaborative Pricing - The NMI emphasizes the need for price coordination among provinces, particularly for those not part of procurement alliances, to address unreasonable price discrepancies [2][11]. - Currently, over thirty procurement initiatives have been launched across provinces, but Shanghai has only implemented a few, indicating a significant workload ahead for 2026 [2][11]. Group 3: Pricing Overview and Tasks - The NMI aims to complete a pricing overview for orthopedic consumables by the end of March [3][12]. - There is a requirement to finalize a comprehensive pricing overview for all medical consumables throughout the year, which is considered a challenging task [5][14]. Group 4: High-Value Consumables Risk Management - The NMI plans to implement concentrated risk management for high-value consumables, with an expectation of six batches of governance actions [6][15]. - This initiative will focus on consumables with significant sales amounts, large regional price differences, and multiple distribution channels [6][15]. Group 5: Alignment with National Directories - Shanghai will align its existing four-level directory with the national three-level directory [7][16]. - Payment policies for new directory items will be clearly marked, indicating potential payment adjustments of 10% or 20% [7][17]. Group 6: Pricing Negotiation Rules - The NMI will enhance the rules for online pricing negotiations and improve the online pricing methods, potentially adjusting the negotiation baseline to the provincial minimum price [7][17]. Group 7: Real-World Research - The NMI has initiated a focus on real-world research, which is considered foundational for pricing strategies [8][18]. - Real-world research involves analyzing data collected from real clinical environments to assess the value and potential risks of medical products and policies [9][18].